Evidence map›Paper›PMID 41890471›Full record

ReviewCureus2026

Prophylactic Mesh Reinforcement Versus Primary Suture for Midline Laparotomy Closure: An Updated Systematic Review and Meta-Analysis.

Marwan Ibrahim, Ali Alseneid, Mara Mijatovic, Ahmed Sultan

Abstract readReview
In one paragraph

Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marwan IbrahimDepartment of General Surgery, Milton Keynes University Hospital, Milton Keynes, GBR.
Ali AlseneidDepartment of General Surgery, William Harvey Hospital, Ashford, GBR.
Mara MijatovicFaculty of Medicine, University of Montpellier, Montpellier, FRA.
Ahmed SultanDepartment of General Surgery, Milton Keynes University Hospital, Milton Keynes, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Incisional hernia remains a common postoperative complication following elective midline laparotomy. Prophylactic mesh reinforcement has been proposed to reduce hernia formation, although concerns regarding postoperative complications and variation in operative technique have limited routine adoption. This systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines and registered on PROSPERO (CRD420251172749). A comprehensive search identified RCTs comparing prophylactic mesh reinforcement with primary suture closure in elective midline laparotomy. The primary outcome was incisional hernia incidence at ≥12 months follow-up. Data were pooled using fixed-effects meta-analysis. Four RCTs comprising 1,006 patients met criteria for quantitative synthesis. Prophylactic mesh significantly reduced the incidence of incisional hernia compared with primary suture closure (relative risk (RR) 0.39, 95% confidence interval (CI) 0.27-0.57). Heterogeneity was moderate (I² = 44.6%). Observational studies supported similar trends without evidence of increased clinically significant wound morbidity. Prophylactic mesh reinforcement reduces the risk of incisional hernia following elective midline laparotomy without clear evidence of increased postoperative complications. Selective use in high-risk patients may improve long-term abdominal wall outcomes, although further standardized studies are warranted.

Indexed as

abdominal wall closureelective laparotomyincisional hernia preventionincisional hernia repairmeta-analysismidline laparotomyprophylactic meshsystematic review

Identifiers

PMID41890471
PMCPMC13015165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.